Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'T(14-18) CHROMOSOMAL TRANSLOCATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 71 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shahidi-Asl, M; Krause, JR
      Molecular pathology of non-Hodgkin lymphomas

      JOURNAL OF CLINICAL LIGAND ASSAY
    2. Papakonstantinou, G; Verbeke, C; Hastka, J; Bohrer, M; Hehlmann, R
      bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements

      BRITISH JOURNAL OF HAEMATOLOGY
    3. Meier, VS; Rufle, A; Gudat, F
      Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18),in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis - A method for the rapid molecular diagnosis of lymphoproliferative disorders applicable to freshfrozen and formalin-fixed, paraffin-embedded tissues, blood, and bone marrow aspirates

      AMERICAN JOURNAL OF PATHOLOGY
    4. King, BE; Chen, C; Locker, J; Kant, J; Okuyama, K; Falini, B; Swerdlow, SH
      Immunophenotypic and genotypic markers of follicular center cell neoplasiain diffuse large B-cell lymphomas

      MODERN PATHOLOGY
    5. Buchonnet, G; Lenain, P; Ruminy, P; Lepretre, S; Stamatoullas, A; Parmentier, F; Jardin, F; Duval, C; Tilly, H; Bastard, C
      Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3 ' BCL2 breakpoints and evidence of a new cluster

      LEUKEMIA
    6. Miura, I; Tamura, A; Taniwaki, M; Nakamura, S; Nakamine, H; Yoshino, T; Ichinohasama, R; Miura, AB
      Detection of t(14;18)(q32;q21) in hyperdiploid cells by fluorescence in situ hybridization in a patient with Hodgkin disease

      CANCER GENETICS AND CYTOGENETICS
    7. Glassman, AB; Hopwood, V; Hayes, KJ
      Cytogenetics as an aid in the diagnosis of lymphomas

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    8. De Brasi, C; Narbaitz, M; Rodriguez, A; Larripa, I; Slavutsky, I
      Bcl-2 molecular analysis in paraffin-embedded biopsies from diffuse large B-cell lymphomas

      MEDICINA-BUENOS AIRES
    9. Groves, FD; Linet, MS; Travis, LB; Devesa, SS
      Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologicsubtype in the United States from 1978 through 1995

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    10. Monni, O; Franssila, K; Joensuu, H; Knuutila, S
      BCL2 overexpression in diffuse large B-cell lymphoma

      LEUKEMIA & LYMPHOMA
    11. Derksen, PWB; Langerak, AW; Kerkhof, E; Wolvers-Tettero, ILM; Boor, PPC; Mulder, AH; Vrints, LWMA; Coebergh, JW; van Krieken, JHJM; Schuuring, E; Kluin, PM; van Dongen, JJM
      Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia

      MODERN PATHOLOGY
    12. Lodgdon, MD; Meyn, RE; Besa, PC; Pugh, WC; Stephens, LC; Peters, LJ; Milas, L; Cox, JD; Cabanillas, F; Brisbay, S; Andersen, M; McDonnell, TJ
      Apoptosis and the BCL-2 gene family - Patterns of expression and prognostic value in stage I and II follicular center lymphoma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    13. Young, NA; Al-Saleem, T
      Diagnosis of lymphoma by fine-needle aspiration cytology using the revisedEuropean-American classification of lymphoid neoplasms

      CANCER CYTOPATHOLOGY
    14. Hosler, GA; Bash, RO; Bai, X; Jain, V; Scheuermann, RH
      Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma

      AMERICAN JOURNAL OF PATHOLOGY
    15. PUGH RE; BITTER MA; SHPALL EJ; HAMI LS; WOLF DM; FRANKLIN WA
      CD19 SELECTION IMPROVES THE SENSITIVITY OF B-CELL LYMPHOMA DETECTION

      Journal of hematotherapy
    16. AKASAKA T; AKASAKA H; YONETANI N; OHNO H; YAMABE H; FUKUHARA S; OKUMA M
      REFINEMENT OF THE BCL2 IMMUNOGLOBULIN HEAVY-CHAIN FUSION GENE IN T(14-18)(Q32-Q21) BY POLYMERASE CHAIN-REACTION AMPLIFICATION FOR LONG TARGETS/

      Genes, chromosomes & cancer
    17. ZHANG GJ; KIMIJIMA I; TSUCHIYA A; ABE R
      THE ROLE OF BCL-2 EXPRESSION IN BREAST CARCINOMAS (REVIEW)

      Oncology Reports
    18. LAI R; ARBER DA; CHANG KL; WILSON CS; WEISS LM
      FREQUENCY OF BCL-2 EXPRESSION IN NON-HODGKINS-LYMPHOMA - A STUDY OF 778 CASES WITH COMPARISON OF MARGINAL ZONE LYMPHOMA AND MONOCYTOID B-CELL HYPERPLASIA

      Modern pathology
    19. XERRI L; BROUSSE N
      GUIDELINES FOR DIAGNOSIS IN HEMATOPATHOLOGY - FOR A RATIONALIZATION OF HISTOLOGICAL, PHENOTYPIC AND GENOTYPIC DIAGNOSIS

      Annales de pathologie
    20. ALSAATI T; GALOIN S; RODA D; HUYNH A; ATTAL M; DELSOL G
      DETECTION OF MINIMAL RESIDUAL DISEASE IN FOLLICULAR LYMPHOMAS USING PCR - VALUE OF CLONOSPECIFIC PROBES

      Bulletin du cancer
    21. LUTHRA R; MCBRIDE JA; HAI S; CABANILLAS F; PUGH WC
      THE APPLICATION OF FLUORESCENCE-BASED PCR AND PCR-SSCP TO MONITOR THECLONAL RELATIONSHIP OF CELLS BEARING THE T(14-18)(Q32-Q21) IN SEQUENTIAL BIOPSY SPECIMENS FROM PATIENTS WITH FOLLICLE CENTER CELL LYMPHOMA

      Diagnostic molecular pathology
    22. OUDEJANS JJ; JIWA NM; VANDENBRULE AJC; MEIJER CJLM
      EPSTEIN-BARR-VIRUS AND ITS POSSIBLE ROLE IN THE PATHOGENESIS OF B-CELL LYMPHOMAS

      Critical reviews in oncology/hematology
    23. GASCOYNE RD
      PATHOLOGICAL PROGNOSTIC FACTORS IN DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Hematology/oncology clinics of North America
    24. KNUTSEN T
      CYTOGENETIC MECHANISMS IN THE PATHOGENESIS AND PROGRESSION OF FOLLICULAR LYMPHOMA

      Cancer surveys
    25. BOYD A; NANNEY L; CAMERON G; KING L
      EXPRESSION OF BCL-2 IN LICHEN-PLANUS, ACUTE GRAFT-VERSUS-HOST DISEASE, AND ERYTHEMA MULTIFORME

      The American journal of dermatopathology
    26. GASCOYNE RD; ADOMAT SA; KRAJEWSKI S; KRAJEWSKA M; HORSMAN DE; TOLCHER AW; OREILLY SE; HOSKINS P; COLDMAN AJ; REED JC; CONNORS JM
      PROGNOSTIC-SIGNIFICANCE OF BCL-2 PROTEIN EXPRESSION AND BCL-2 GENE REARRANGEMENT IN DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Blood
    27. YERLYMOTTA V; RACADOT E; FEST T; BASTARD C; FERRAND C; DESCHASEAUX ML; HERVE P
      COMPARATIVE PRECLINICAL STUDY OF 3 BONE-MARROW PURGING METHODS USING PCR EVALUATION OF RESIDUAL T(14-18) LYMPHOMA-CELLS

      Leukemia & lymphoma
    28. FRENOY N; GILDELGADO M; PHAM P; SALVUCCI M; CHAHINE A; CHABLI A; MISSET JL; DEBUIRE B
      MOLECULAR ANALYSIS OF LYMPHOID MALIGNANCIES - A REPORT OF 41 CASES

      Oncology Reports
    29. BETTICHER DC; ZUCCA E; VONROHR A; EGGER T; RADFORD JA; AMBROSETTI A; BURKI K; RUFENER B; SCHMITZ SFH; CERNY T
      2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH FOLLICULAR STAGE III-IV NON-HODGKINS-LYMPHOMA

      Annals of oncology
    30. ZUCCA E; BERTONI F; BOSSHARD G; ROGGERO E; CERESA E; SANNA P; PEDRINIS E; CAVALLI F
      CLINICAL-SIGNIFICANCE OF BCL-2 (MBR) J(H) REARRANGEMENT IN THE PERIPHERAL-BLOOD OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMAS/

      Annals of oncology
    31. TAKAHASHI H; KAWAZOE F; FUJITA S; OKABE H; HIDESHIMA K; TSUDA N; TEZUKA F
      EXPRESSION OF BCL-2 ONCOGENE PRODUCT IN PRIMARY NON-HODGKINS MALIGNANT-LYMPHOMA OF THE ORAL CAVITY

      Pathology research and practice
    32. CHIMENTI S; CERRONI L; ZENAHLIK P; PERIS K; KERL H
      THE ROLE OF MT2 AND ANTI-BCL-2 PROTEIN ANTIBODIES IN THE DIFFERENTIATION OF BENIGN FROM MALIGNANT CUTANEOUS INFILTRATES OF B-LYMPHOCYTES WITH GERMINAL CENTER FORMATION

      Journal of cutaneous pathology
    33. CRISAN D
      BCL-2 GENE REARRANGEMENTS IN LYMPHOID MALIGNANCIES

      Clinics in laboratory medicine
    34. KOJIMA M; NAKAMURA S; MOTOORI T; KURABAYASHI Y; HOSOMURA Y; ITOH H; YOSHIDA K; SUZUKI R; SETO M; KOSHIKAWA T; SUCHI T; JOSHITA T
      CENTROBLASTIC AND CENTROBLASTIC-CENTROCYTIC LYMPHOMAS ASSOCIATED WITHPROMINENT EPITHELIOID GRANULOMATOUS RESPONSE WITHOUT PLASMA-CELL DIFFERENTIATION - A CLINICOPATHOLOGICAL STUDY OF 12 CASES

      Human pathology
    35. MERUP M; SPASOKOUKOTSKAJA T; EINHORN S; SMITH CI; GAHRTON G; JULIUSSON G
      BCL-2 REARRANGEMENTS WITH BREAKPOINTS IN BOTH VCR AND MBR IN NON-HODGKINS-LYMPHOMAS AND CHRONIC LYMPHOCYTIC-LEUKEMIA

      British Journal of Haematology
    36. HILL ME; MACLENNAN KA; CUNNINGHAM DC; HUDSON BV; BURKE M; CLARKE P; DISTEFANO F; ANDERSON L; HUDSON GV; MASON D; SELBY P; LINCH DC
      PROGNOSTIC-SIGNIFICANCE OF BCL-2 EXPRESSION AND BCL-2 MAJOR BREAKPOINT REGION REARRANGEMENT IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA - ABRITISH NATIONAL LYMPHOMA INVESTIGATION STUDY

      Blood
    37. NGUYEN PL; ZUKERBERG LR; BENEDICT WF; HARRIS NL
      IMMUNOHISTOCHEMICAL DETECTION OF P53, BCL-2, AND RETINOBLASTOMA PROTEINS IN FOLLICULAR LYMPHOMA

      American journal of clinical pathology
    38. CERRONI L; SOYER HP; KERL H
      EXPRESSION OF BCL-2 PROTEIN (BCL-2) IN CUTANEOUS NEOPLASMS - AN IMMUNOHISTOCHEMICAL STUDY OF 259 BENIGN AND MALIGNANT-TUMORS OF THE SKIN

      EJD. European journal of dermatology
    39. NOLTE M; WERNER M; SPANN W; SCHNABEL B; VONWASIELEWSKI R; WILKENS L; HUBNER K; FISCHER R; GEORGII A
      THE BCL-2 JH GENE REARRANGEMENT IS UNDETECTABLE IN HODGKINS LYMPHOMAS- RESULTS FROM THE GERMAN HODGKIN TRIAL/

      Virchows Archiv
    40. JIWA NM; OUDEJANS JJ; BAI MC; VANDENBRULE AJC; HORSTMAN A; VOS W; VANDERVALK P; KLUIN PHM; WALBOOMERS JMM; MEIJER CJLM
      EXPRESSION OF BCL-2 PROTEIN AND TRANSCRIPTION OF THE EPSTEIN-BARR-VIRUS BCL-2 HOMOLOG BHRF-1 IN HODGKINS-DISEASE - IMPLICATIONS FOR DIFFERENT PATHOGENIC MECHANISMS

      Histopathology
    41. TRISCOTT JA; RITTER JH; SWANSON PE; WICK MR
      IMMUNOREACTIVITY FOR BCL-2 PROTEIN IN CUTANEOUS LYMPHOMAS AND LYMPHOID HYPERPLASIAS

      Journal of cutaneous pathology
    42. LORENZEN J; ALAVAIKKO M; HANSMANN ML
      APOPTOSIS IN HODGKINS-DISEASE

      Der Pathologe
    43. KNEBA M; EICK S; HERBST H; POTT C; BOLZ I; DALLENBACH F; HIDDEMANN W; STEIN H
      LOW INCIDENCE OF MBR BCL-2 J(H) FUSION GENES IN HODGKINS-DISEASE/

      Journal of pathology
    44. JI WZ; QU GZ; YE P; ZHANG XY; HALABI S; EHRLICH M
      FREQUENT DETECTION OF BCL-2 J(H) TRANSLOCATIONS IN HUMAN BLOOD AND ORGAN SAMPLES BY A QUANTITATIVE POLYMERASE CHAIN-REACTION ASSAY/

      Cancer research
    45. ERAY M; TUOMIKOSKI T; WU HY; NORDSTROM T; ANDERSSON LC; KNUUTILA S; KAARTINEN M
      CROSS-LINKING OF SURFACE IGG INDUCES APOPTOSIS IN A BCL-2 EXPRESSING HUMAN FOLLICULAR LYMPHOMA LINE OF MATURE B-CELL PHENOTYPE

      International immunology
    46. COTTER FE; JOHNSON P; HALL P; POCOCK C; ALMAHDI N; COWELL JK; MORGAN G
      ANTISENSE OLIGONUCLEOTIDES SUPPRESS B-CELL LYMPHOMA GROWTH IN A SCID-HU MOUSE MODEL

      Oncogene
    47. MITANI S; OKA T; AOKI N; HOJO I; OTA U; MORI S
      REARRANGEMENT OF BCL-2 IS DETECTABLE IN HODGKINS-DISEASE BY POLYMERASE CHAIN-REACTION

      Japanese journal of cancer research
    48. KNUUTILA S; KLEFSTROM J; SZYMANSKA J; LAKKALA T; PELTOMAKI P; ERAY M; TEERENHOVI L; ELONEN E; FRANSSILA KO; KAARTINEN M
      2 NOVEL HUMAN B-CELL LYMPHOMA LINES OF LYMPHATIC FOLLICLE ORIGIN - CYTOGENETIC, MOLECULAR-GENETIC AND HISTOPATHOLOGICAL CHARACTERIZATION

      European journal of haematology
    49. BENEZRA JM; KING BE; HARRIS AC; TODD WM; KORNSTEIN MJ
      STAINING FOR BCL-2 PROTEIN HELPS TO DISTINGUISH BENIGN FROM MALIGNANTLYMPHOID AGGREGATES IN BONE-MARROW BIOPSIES

      Modern pathology
    50. KUBE MJ; MCDONALD DA; QUIN JW; GREENBERG ML
      USE OF ARCHIVAL AND FRESH CYTOLOGIC MATERIAL FOR THE POLYMERASE CHAIN-REACTION - DETECTION OF THE BCL-2 ONCOGENE IN LYMPHOID-TISSUE OBTAINED BY FINE-NEEDLE BIOPSY

      Analytical and quantitative cytology and histology
    51. GRIBBEN JG
      ATTAINMENT OF MOLECULAR REMISSION - A WORTHWHILE GOAL

      Journal of clinical oncology
    52. CERRONI L; KERL H
      ABERRANT BCL-2 PROTEIN EXPRESSION PROVIDES A POSSIBLE MECHANISM OF NEOPLASTIC CELL-GROWTH IN CUTANEOUS BASAL-CELL CARCINOMA

      Journal of cutaneous pathology
    53. COTTER FE
      THE ROLE OF POLYMERASE CHAIN-REACTION IN PATHOLOGY

      Journal of histotechnology
    54. MIES C
      MOLECULAR BIOLOGICAL ANALYSIS OF PARAFFIN-EMBEDDED TISSUES

      Human pathology
    55. CERRONI L; VOLKENANDT M; RIEGER E; SOYER HP; KERL H
      BCL-2 PROTEIN EXPRESSION AND CORRELATION WITH THE INTERCHROMOSOMAL-1418 TRANSLOCATION IN CUTANEOUS LYMPHOMAS AND PSEUDOLYMPHOMAS

      Journal of investigative dermatology
    56. HARRIS NL; JAFFE ES; STEIN H; BANKS PM; CHAN JKC; CLEARY ML; DELSOL G; DEWOLFPEETERS C; FALINI B; GATTER KC; GROGAN TM; ISAACSON PG; KNOWLES DM; MASON DY; MULLERHERMELINK HK; PILERI SA; PIRIS MA; RALFKIAER E; WARNKE RA
      A REVISED EUROPEAN-AMERICAN CLASSIFICATION OF LYMPHOID NEOPLASMS - A PROPOSAL FROM THE INTERNATIONAL LYMPHOMA STUDY-GROUP

      Blood
    57. LEBRUN DP; NGAN BY; WEISS LM; HUIE P; WARNKE RA; CLEARY ML
      THE BCL-2 ONCOGENE IN HODGKINS-DISEASE ARISING IN THE SETTING OF FOLLICULAR NON-HODGKINS-LYMPHOMA

      Blood
    58. OLEARY TJ; STETLERSTEVENSON M
      DIAGNOSIS OF T(1418) BY POLYMERASE CHAIN-REACTION - THE NATURAL EVOLUTION OF A LABORATORY TEST

      Archives of pathology and laboratory medicine
    59. BENEZRA JM; KORNSTEIN MJ; GRIMES MM; KRYSTAL G
      SMALL-CELL CARCINOMAS OF THE LUNG EXPRESS THE BCL-2 PROTEIN

      The American journal of pathology
    60. LONES MA; PINKUS GS; SHINTAKU IP; SAID JW
      BCL-2 ONCOGENE PROTEIN IS PREFERENTIALLY EXPRESSED IN REED-STERNBERG CELLS IN HODGKINS-DISEASE OF THE NODULAR SCLEROSIS SUBTYPE

      American journal of clinical pathology
    61. CORBALLY N; GROGAN L; KEANE MM; DEVANEY DM; DERVAN PA; CARNEY DN
      BCL-2 REARRANGEMENT IN HODGKINS-DISEASE AND REACTIVE LYMPH-NODES

      American journal of clinical pathology
    62. SWERDLOW SH; UTZ GL; WILLIAMS ME
      BCL-2 PROTEIN IN CENTROCYTIC LYMPHOMA - A PARAFFIN SECTION STUDY

      Leukemia
    63. COTTER FE
      MOLECULAR PATHOLOGY OF LYMPHOMAS

      Cancer surveys
    64. NOLTE M; WERNER M; SPANN W; SCHNABEL B; VONWASIELEWSKI R; WILKENS L; GEORGII A
      THE BCL-2 JH REARRANGEMENT IS PRESENT IN NON-HODGKINS-LYMPHOMA AND CHRONIC TONSILLITIS, BUT NOT IN HODGKINS LYMPHOMA - A MOLECULAR-GENETIC AND IMMUNOHISTOCHEMICAL INVESTIGATION/

      Der Pathologe
    65. SLOVAK ML; WEISS LM; NATHWANI BN; BERNSTEIN L; LEVINE AM
      CYTOGENETIC STUDIES OF COMPOSITE LYMPHOMAS - MONOCYTOID B-CELL LYMPHOMA AND OTHER B-CELL NON-HODGKIN LYMPHOMAS

      Human pathology
    66. WALTON MI; WHYSONG D; OCONNOR PM; HOCKENBERY D; KORSMEYER SJ; KOHN KW
      CONSTITUTIVE EXPRESSION OF HUMAN BCL-2 MODULATES NITROGEN-MUSTARD ANDCAMPTOTHECIN INDUCED APOPTOSIS

      Cancer research
    67. CHEN PM; LIN SH; SETO M; CHAO SC; CHIOU TJ; HSIEH RK; LIN CZ; FAN S; TZENG CH; UEDA R; LIU JH
      REARRANGEMENT OF BCL-2 GENES IN MALIGNANT-LYMPHOMAS IN CHINESE PATIENTS

      Cancer
    68. YUAN R; DOWLING P; ZUCCA E; DIGGELMANN H; CAVALLI F
      DETECTION OF BCL-2 JH REARRANGEMENT IN FOLLICULAR AND DIFFUSE LYMPHOMA - CONCORDANT RESULTS OF PERIPHERAL-BLOOD AND BONE-MARROW ANALYSIS ATDIAGNOSIS/

      British Journal of Cancer
    69. JOHNSON PWM; WATT SM; BETTS DR; DAVIES D; JORDAN S; NORTON AJ; LISTER TA
      ISOLATED FOLLICULAR LYMPHOMA-CELLS ARE RESISTANT TO APOPTOSIS AND CANBE GROWN IN-VITRO IN THE CD40 STROMAL CELL SYSTEM

      Blood
    70. RATECH H
      THE USES OF MOLECULAR-BIOLOGY IN HEMATOPATHOLOGY - ONCOGENES AS DIAGNOSTIC MARKERS IN NON-HODGKINS MALIGNANT-LYMPHOMA

      American journal of clinical pathology
    71. WEISENBURGER DD; CHAN WC
      LYMPHOMAS OF FOLLICLES - MANTLE CELL AND FOLLICLE CENTER CELL LYMPHOMAS

      American journal of clinical pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 00:12:18